How can surgical robotics manufacturers deliver targeted innovations that dramatically improve patient outcomes and cost-efficiency in healthcare? It’s about developing procedural solutions that clearly surpass what humans can achieve. Clinical and financial benefits need to be tangible and measurable, so end-users can build a robust business case for investment. By Rob Morgan, VP Medical, Sagentia.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
MedTech Strategist, the industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today.Subscribe Browse Latest Issue
Registration is now open for the 7th annual Innovation Summit Dublin, April 21-23, 2020. The industry's most anticipated event will sell out. Register Today.Register Learn More
Now that large cardiology companies have demonstrated the value of measuring heart failure parameters with implantable devices, a new generation of companies hopes to do the same non-invasively with wearable devices. ReThink Medical has reduced a number of complex engineering challenges to a wearable wristband that gathers several physiological signals important for detecting worsening heart failure early.Subscribe now to read the full analysis
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.Subscribe Free Premier Issue Learn More
Wearables are a hot topic in medtech circles today. But are they really medtech? Cala Health’s Trio device for treating essential tremors underscores the challenges and opportunities that wearables represent when compared to traditional medical devices.Subscribe now to read the full analysis